Aramark director granted dividend equivalent rights

Aramark director Kenneth M. Keverian acquired additional equity-linked rights through a Form 4 transaction.

Rhea-AI Filing Summary

Aramark director Kenneth M. Keverian acquired additional equity-linked rights through a Form 4 transaction. On 2026-03-04, he was granted 84.6900 dividend equivalent rights in connection with Aramark’s quarterly dividend, tied to deferred stock units he already holds.

These dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards. Following this grant, Keverian’s directly owned position in Aramark common stock and related equity units totaled 29077.2060 shares.

Insider Trade Summary

Grant/Award: 84.69 shares

Grant/Award 1 txn

Insider KEVERIAN KENNETH M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	84.69	$0.00	$0.00

Holdings After Transaction: Common Stock — 29,077.206 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Kenneth M. Keverian?

Aramark reported that director Kenneth M. Keverian acquired 84.6900 dividend equivalent rights on 2026-03-04. These rights are tied to deferred stock units and arise from Aramark’s quarterly dividend, increasing his total directly held common stock and related equity units to 29077.2060 shares.

How many Aramark dividend equivalent rights did Kenneth M. Keverian receive?

Kenneth M. Keverian received 84.6900 dividend equivalent rights connected to Aramark’s quarterly dividend. These rights accrue on deferred stock units he holds and follow the same vesting schedule as the underlying awards, modestly increasing his overall equity-linked exposure to Aramark common stock.

What are the dividend equivalent rights disclosed for Aramark director Kenneth M. Keverian?

The dividend equivalent rights represent amounts accruing on Keverian’s deferred stock units in connection with Aramark’s quarterly dividend. According to the disclosure, these dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards, aligning their timing with existing equity incentives.

What is Kenneth M. Keverian’s Aramark equity position after this Form 4 transaction?

After the reported grant, Kenneth M. Keverian directly holds 29077.2060 shares of Aramark common stock and related equity units. This figure includes the newly acquired 84.6900 dividend equivalent rights that accrued on his deferred stock units due to Aramark’s quarterly dividend.

Was cash paid for the dividend equivalent rights reported in Aramark’s Form 4?

The Form 4 lists a transaction price per share of 0.0000 for the 84.6900 dividend equivalent rights. This indicates the rights were granted in connection with Aramark’s quarterly dividend on existing deferred stock units rather than acquired through an open-market cash purchase of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KEVERIAN KENNETH M

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		84.69(1)	A	$0	29,077.206	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.